Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum QLT INC T.QLT

"QLT Inc is a biotechnology company conducts development and commercialization of ocular products that address the unmet medical needs of patients and clinicians."

TSX:QLT - Post Discussion

QLT INC > Aralez Pharmas
View:
Post by silvertrade on Feb 29, 2016 4:13am

Aralez Pharmas

Come to our facebook group for the best quality discussion on Aralez. No bashers. Search on FB Groups: "Aralez Pharmaceuticals Investors"
Comment by thedave2006 on Apr 04, 2016 9:03am
with next few days, arz done....lol what an erosion of qlt and arz sps. :(
Comment by thedave2006 on Apr 12, 2016 9:21am
miserable let down in QLT SP and ARZ SP....only lucky ones are those who got cash of $6.75 US which equals to about $8 CDN or thereabouts. I ended up with all ARZ shares and got about $3 to catch up with so I am = to those shareholders that got all cash instead of ARZ shares....now let see if investors and/or MMs can move QLT and/or ARZ up so I can get out. LOL!!!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities